insights_auto
Why is GXE up 2,83%?
Dive Deeperchevron_right
GXE:ETR
Lakefront Biotherapeutics NV
26,88 €
arrow_upward
+2,83%(+0,74) 1D
15-окт., 16:19:03 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GXE...
Open
26,06 €
High
26,88 €
Low
26,06 €
Mkt. cap
1,77 млд
Avg. vol.
602,00
Volume
1,03 миң
P/E ratio
2,97
52-wk high
30,02 €
52-wk low
22,84 €
EPS
9,05 €
No. of employees
196
Open
26,06 €
High
26,88 €
Low
26,06 €
Mkt. cap
1,77 млд
Avg. vol.
602,00
Volume
1,03 миң
P/E ratio
2,97
52-wk high
30,02 €
52-wk low
22,84 €
EPS
9,05 €
No. of employees
196
News stories
From web sources and news partners
Stock Titan
·
1 саат мурун
An energy-efficiency platform's co-founder becomes a director; its CEO joins TROOPS as COO.
bloomingbit
·
6 мүнөт мурун
Nasdaq-Listed Tron Files $200 Million Stock Offering to Fund TRX Purchases
Central Oregon Daily
·
18 мүнөт мурун
Nasdaq slides to near one-month low as AI rout deepens
CNN
·
3 саат мурун
Global tech sell-off deepens as enthusiasm for AI stocks wobbles
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV